Literature DB >> 19237496

Pushed and pulled: the role of affect and cognition in shaping CAM attitudes and behavior among men treated for prostate cancer.

Matthew C Porter1, Michael A Diefenbach.   

Abstract

We used Self-Regulation Theory (SRT) to elaborate and describe cognitive and affective representations presumed to underlie CAM decisions in a sample of 55 men who were using CAM after having received conventional treatment for early-stage, localized prostate cancer. Positive representations of CAM were the strongest predictors of beliefs that CAM was necessary for one's health (a 'pulling' effect toward CAM). Nonetheless, negative representations of conventional medicine made an important, though somewhat lesser contribution (a ;pushing' effect away from conventional medicine and towards CAM). Our results also indicate preliminarily that affect may be more important than cognition in shaping CAM decisions.

Entities:  

Mesh:

Year:  2009        PMID: 19237496     DOI: 10.1177/1359105308100213

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  4 in total

1.  [Importance of complementary medicine approaches for patients with prostate cancer].

Authors:  K M Gschwendtner; G Klein; C Güthlin; C Holmberg; M Horneber; J Weis
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

2.  The role of complementary and alternative medicine (CAM) routines and rituals in men with cancer and their significant others (SOs): a qualitative investigation.

Authors:  Nadja Klafke; Jaklin A Eliott; Ian N Olver; Gary A Wittert
Journal:  Support Care Cancer       Date:  2013-12-24       Impact factor: 3.603

3.  Predicting adherence to acupuncture appointments for low back pain: a prospective observational study.

Authors:  Felicity L Bishop; Lucy Yardley; Cyrus Cooper; Paul Little; George Lewith
Journal:  BMC Complement Altern Med       Date:  2017-01-03       Impact factor: 3.659

4.  Understanding CAM Use in Lebanon: Findings from a National Survey.

Authors:  Samer Kharroubi; Rana F Chehab; Chirine El-Baba; Mohamad Alameddine; Farah Naja
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-25       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.